NOD1

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
US 7078165 B2Applicant: PASTEUR INSTITUTPriority: 2004
US
5 publications
Method for inducing lymphoid tissue and modulating intestinal homeostasis
US 8425920 B2Applicant: EBERL GERARDPriority: 2009
US
4 publications
NOD1 MODULATORS AND USES THEREOF
EP 4536275 A4Applicant: ACADEMIA SINICAPriority: 2022
EP
US
WO
3 publications
LOCAL ADMINISTRATION OF RIPK2 INHIBITORS FOR THE CURATIVE TREATMENT OF ALLERGIC ASTHMA
EP 4791396 A1Applicant: INST NAT SANTE RECH MEDPriority: 2023
EP
WO
2 publications
Method of screening modulators of Nod1 signaling
US 7244557 B2Applicant: UNIV MICHIGANPriority: 2004
US
2 publications
Modulators of Nod1 signaling
US 2006258580 A1Applicant: UNIV OSAKAPriority: 2005
US
2 publications
NOD1 as an anti-tumor agent
- US 2006194740 A1
  Applicant: ULEVITCH RICHARD JPriority: 2006
  US
  2 publications
- CN 101287501 A
  Applicant: SCHWEGMAN LUNDBERG & WOESSNERPriority: 2005
  CN
Antisense modulation of NOD1 expression
US 2003119767 A1Applicant: ISIS PHARMACEUTICALS INCPriority: 2001
US
Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI)
US 2006084090 A1Applicant: FERRERO RICHARDPriority: 2005
US
Method for screening molecules that restore NOD1 activity in cells containing an NOD2 mutation that reduces or eliminates NOD1 activity
US 2006251659 A1Applicant: GIRARDIN STEPHENPriority: 2006
US

Drugs

NOD1

Patents

NOD1 as an anti-tumor agent